USPTO Rejects Claims of Two Illumina Patents in Non-Final Action After Life Tech Reexam Request
May 11, 2010
USPTO Rejects Claims of Two Illumina Patents in Non-Final Action After Life Tech Reexam Request
Because of the US Patent and Trademark Office's current review of four Illumina patents, Life Tech has requested to suspend all proceedings in ongoing litigation involving the IP.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- In Sequence Annual Survey: Illumina Leads Market but Most Users Believe PacBio Will Provide Next Big Leap
January 25, 2011 / In Sequence - New Sequencing Platforms Drive Choice, Competition, Lawsuits in 2010
January 4, 2011 / In Sequence - Cancer Sequencing with High Coverage on Two Platforms Improves Mutation Detection, Baylor Team Says
July 6, 2010 / In Sequence - Survey: Illumina, SOLiD, and 454 Gain Ground in Research Labs; Most Users Mull Additional Purchases
January 19, 2010 / In Sequence - In New Suit, Illumina Says Ion Torrent PGM Infringes Bead Array IP
January 3, 2012 / In Sequence